Who owns the COMPLETE VACCINE trademark?

The COMPLETE VACCINE trademark is owned by Nugenerex Immuno-Oncology.

What class is the COMPLETE VACCINE trademark registered in?

The COMPLETE VACCINE trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for COMPLETE VACCINE?

The USPTO serial number for COMPLETE VACCINE is 90301335.

What is the registration number for COMPLETE VACCINE?

COMPLETE VACCINE is registered under USPTO registration number 0.

Sealvo

Home Search: COMPLETE VACCINECOMPLETE VACCINE #90301335

Back

Updated Sep 30, 2026·18 searches this week

View on USPTO TSDR Find similar marks

COM

USPTO Trademark Record

ABANDONED

COMPLETE VACCINE

SN 90301335·Reg 0·Filed Nov 05, 2020

Owner Nugenerex Immuno-Oncology

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

COMPLETE VACCINE (Serial No. 90301335), Registration No. 0, is a abandoned US trademark filed on Nov 05, 2020 by Nugenerex Immuno-Oncology. This trademark covers Class 042 (Scientific, technology & SaaS services).

Conflict Analysis

Full conflict analysis for COMPLETE VACCINE (SN 90301335) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

COMPLETE VACCINE (Reg. #0) is an abandoned US trademark that was filed in 2020 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Nov 05, 2020

SERIAL

90301335

REG#

REGISTERED

Dec 31, 1969

Filing Information

StatusABANDONED

Filing DateNov 05, 2020

Serial Number90301335

Registration No.0

Registration DateDec 31, 1969

Status DateSep 05, 2022

Published for OppositionDec 07, 2021

Filing Basis & Declarations

Standard Characters Claimed

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

16 events

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Sep 06, 2022

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

ABANDONMENT - NO USE STATEMENT FILED

Sep 05, 2022

ABANDONMENT - NO USE STATEMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 01, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Dec 07, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 07, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 17, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 01, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 26, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 25, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 25, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Apr 23, 2021

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Apr 23, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 23, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Apr 12, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 06, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Nov 09, 2020

NEW APPLICATION ENTERED

Other Marks by Nugenerex Immuno-Oncology

Additional USPTO filings from the same owner.

COM

COMPLETE VACCINE

90301302

Nugenerex Immuno-Oncology

ABANDONED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

IVI

IVIR VACCINE

88934131

IVIR VACCINE, INC.

REGISTERED

COM

COMPLETE

97354349

AbbVie Biotechnology Ltd

REGISTERED

COM

[COMPLETE]

90090145

Lotus Techpros, LLC

REGISTERED

SAB

SABIN VACCINE INSTITUTE

90276592

Albert B. Sabin Vaccine Institute, Inc.

REGISTERED

Other Marks by Jeffrey J. King

Additional USPTO filings handled by the same attorney of record.

COG

COGNITIVE EXPLORATIONS

98134259

REGISTERED

PUR

PURSEMASK

90301145

REGISTERED

COR

CORGENE

50040486

PENDING

PRO

PROTECTEDEQUITY

50038828

PENDING

COMPLETE VACCINE

Run a conflict check

Other Marks by Nugenerex Immuno-Oncology

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Jeffrey J. King

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company